NJR
18 FDA 510(k) clearances · Product code
133 daysmedian time to decision
485 days90th percentile
18clearances measured
FDA profile
- Official device name
- Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 866.3740
- Medical specialty
- Microbiology
- FDA definition
- A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of group b streptococci from pre-partum and intra-partum women to establish colonization status.
- Adverse events (MAUDE)
- 2026: 49
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
Track NJR automatically
Every clearance here is in the API, with alerts when new ones post.